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Abstract Endoscopic retrograde cholangiopancreatography
(ERCP) is currently a primarily therapeutic procedure
tha t i s ex tens ive ly employed to t rea t severa l
biliopancreatic disorders. Although widely considered a
safe procedure, ERCP is associated with a non-
negligible morbidity and occasional mortality. Due to
the number and complexity of operative ERCPs per-
formed, radiologists are increasingly faced with urgent
requests for investigation of suspected post-procedural
complications, which often have similar clinical and lab-
oratory manifestations. This pictorial essay reviews the
usual post-procedural CT findings, the clinical features
and imaging appearances of common and unusual post-
ERCP occurrences including interstitial oedematous and
necrotising acute pancreatitis, haemorrhages, retroperito-
neal and intraperitoneal duodenal perforations, infections
and stent-related complications. Emphasis is placed on
the pivotal role of multidetector CT, which is warranted
after complex or prolonged ERCP procedures as it rep-
resents the most effective modality to detect and grade
ERCP- r e l a t e d comp l i c a t i on s and t o mon i t o r
nonsurgically treated patients. Timely diagnosis and op-
timal management require a combination of clinical and
laboratory data with imaging appearances; therefore, this
article aims to provide an increased familiarity with in-
terpretation of early post-ERCP studies, particularly to
triage those occurrences that require interventional or
surgical treatment. In selected patients MRI allows
imaging pancreatitis and abnormal collections without
the use of ionising radiation.
Teaching Points
• Endoscopic retrograde cholangiopancreatography (ERCP)
allows treating many biliopancreatic disorders.
• Due to the number and complexity of procedures, post-
ERCP complications are increasingly encountered.
• Main complications include acute pancreatit is,
haemorrhages, duodenal perforation and infections.
• Diagnosis and management of complications rely on com-
bined clinical, laboratory and imaging data.
• Multidetector CT is most effective to diagnose, categorise
and monitor post-ERCP complications.
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Introduction
Background
Due to the widespread availability of non-invasive imaging tech-
niques such as magnetic resonance cholangiopancreatography
(MRCP) and multidetector computed tomography (CT), during
the last decade endoscopic retrograde cholangiopancreatography
(ERCP) has evolved from a diagnostic tool towards a primarily
therapeutic procedure. Currently indispensable in surgical prac-
tice, ERCP is extensively used to treat several disorders of the
biliopancreatic system so that over 500,000 procedures are per-
formed yearly in the USA [1].
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The growing number of indications for ERCP encom-
pass retained or recurrent choledocholithiasis, benign
and malignant biliary strictures, ampullary stenosis,
sphincter of Oddi dysfunction (SOD), postoperative
and traumatic ductal injuries, acute gallstone and chron-
ic pancreatitis. Widely considered a safe procedure that
often obviates the need for surgery (particularly in frail
patients with poor performance status), ERCP has lim-
ited contraindications such as upper aerodigestive ob-
struction, severe coagulopathy, oesophageal and/or gas-
tric varices, anaphylactic reaction to iodinated contrast
medium (CM), acute nonbiliary pancreatitis, severe car-
diopulmonary impairment and recent myocardial infarc-
tion. ERCP is technically challenging in patients with
pancreatico-duodenectomy or Billroth type II surgical
reconstruction, unfeasible with the previous Roux-en-Y
anastomosis. Following identification and cannulation of
the ampullary orifice and CM injection under fluorosco-
py, current endoscopic equipment allows performing
sphincterotomy, extraction of common bile duct (CBD)
stones, lithotripsy, biliary drainage, stricture dilatation,
brush cytology and biopsy [1–3].
Furthermore, endoscopic positioning of biliary pros-
theses allows minimally invasive management of ob-
structive jaundice from benign and neoplastic causes
with high technical (over 90 %) and clinical (approxi-
mately 80 %) success rates. Plastic stents are commonly
used to treat benign strictures, postoperative bile leaks
and pancreatic diseases. Conversely, self-expanding met-
al stents (SEMS) may provide effective palliation of
malignant biliary obstruction [4, 5].
However, ERCP is associated with a non-negligible
post-procedural morbidity (estimated in the range 4–
10 % overall). The most common short-term (occurring
within 3 days) complications include more or less se-
vere cardiopulmonary problems (hypoxia, arrhythmia
and aspiration) commonly associated with medications
used for sedation and analgesia. The reported incidence
of ERCP-specific complications ranges from 5 to 40 %,
depending on the underlying diagnosis, patient age and
comorbidities, complexity of the procedure, and operator
experience. The most common occurrences include post-
ERCP acute pancreatitis (PEAP, 2–9 %), haemorrhage
(1.3–3.7 %), infection (1.9–3.6 %) and duodenal perfo-
ration (DP) in descending order of frequency. Addition-
ally, a variety of rare complications have been occasion-
ally reported, including pneumothorax, portal venous air
embolism, splenic injury and perforation of colonic di-
verticula [2, 6–9].
The risk of complications is increased by operative
techniques such as use of balloons and dilating cathe-
ters, tissue sampling, mechanical lithotripsy and wire
baskets for stone extraction, and plastic and metallic
biliary stents. Mostly related to operative procedures,
ERCP-related mortality (0.5–1.4 %) may result from
any of the above-mentioned complications and is partic-
ularly high in elderly patients with comorbidities and in
centres with limited caseloads [2, 6–8, 10].
Aim
According to the guidelines issued by the American
Society for Gastrointestinal Endoscopy (ASGE) and the
World Society of Emergency Surgery (WSES), diagnosis
and management of ERCP-related complications should
rely upon a combination of clinical, laboratory and im-
aging data. Since iatrogenic complications represent a
non-negligible cause of litigation and lawsuits, early
recognition and prompt appropriate intervention are es-
sential in optimising patient management and outcome
[6, 11, 12].
Based upon 8 years of personal experience at a
university-based general hospital where approximately
230 ERCPs are performed each year, this pictorial essay
reviews and illustrates the normal post-procedural ap-
pearances observed shortly after ERCP, and the imaging
findings associated with common and unusual complica-
tions, aiming to provide radiologists with an increased
familiarity with interpretation of early post-procedural
studies for an optimal triage of complications. Most of
the emphasis is placed on the pivotal role of multide-
tector CT, which represents, according to the WSES
guidelines for management of intra-abdominal infec-
tions, the preferred and most effective modality to com-
prehensively investigate the abdomen and pelvis to
search for possible iatrogenic complications [6, 12–15].
Early post-ERCP imaging: indications, techniques, usual
findings and reactive changes
Clinical features and indications for imaging
In the vast majority of cases, the clinical suspicion of
early iatrogenic complications is based on a combination
of intraprocedural findings (difficult or repeated cannu-
lation, suspected or confirmed DP), symptoms and
physical signs (sudden or worsening abdominal pain,
distension, fever, haemodynamic impairment) and labo-
ratory data (decreasing haemoglobin, elevated leukocyte
count, acute phase reactants, serum lipase or amylase).
The key role of CT imaging to investigate patients who
become acutely ill hours or days after ERCP results
from the limited value of physical examination (due to
the retroperitoneal location of most iatrogenic changes)
and the similar clinical and laboratory manifestations
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observed in most complications, particularly AP and DP
[2, 6, 12].
Furthermore, ERCP duration may represent a surro-
gated marker for challenging cannulation and/or opera-
tive manoeuvres that can lead to papillary oedema and
compromise ductal outflow, thus resulting in an in-
creased risk and severity of complications, particularly
PEAP. According to both the literature and personal
experience, planned CT may be warranted in patients
after prolonged ERCP procedures, particularly with
sphincterotomy or multiple cannulations [16].
CT technique, usual post-procedural findings and reactive
changes
A preliminary unenhanced CT acquisition without intra-
venous and peroral CM is helpful to visualise
extraluminal air (particularly using image review at lung
or bone window settings) and hyperattenuating (35–70
Hounsfield units, HU) fresh blood. Afterwards, follow-
ing standard-dose intravenous CM injection we recom-
mend a biphasic (arterial-dominant and venous) acquisi-
tion, particularly to identify pancreatic necrosis and CM
extravasation indicating active bleeding. Additionally, in
selected cases gastroduodenal opacification by means of
peroral ingestion of diluted enteral CM may be benefi-
cial to confirm or exclude leakage indicating DP
(Fig. 1) [6, 13–15].
After ERCP the presence of air in the biliary tree is
an expected, common finding. Intra- and extrahepatic
pneumobilia is visible in the majority of patients studied
with CT within a few weeks from the procedure and
may persist for months or years in patients who
underwent sphincterotomy (Fig. 2). Shortly after ERCP
retained CM is commonly seen in the biliary tree and
gallbladder, often with a characteristic stratified appear-
ance (Fig. 2) [13, 15].
Multiplanar CT reformations (Figs. 2 and 3) provide
high-resolution visualisation of biliary endoprostheses,
whether of plastic or metallic reticular Bmesh^ material,
and of their anatomical relationships. When interpreting
post-procedural studies, the stent type should be report-
ed along with the integrity, patency and position includ-
ing proximal and distal extremities [13, 17].
In up to 29 % of asymptomatic patients, limited ret-
roperitoneal air observed within 24 h from ERCP may
result from excessive insufflation during and after endo-
scope withdrawal. Although this occurrence is
categorised as type IV perforation according to the
Stapfer classification (Table 1), we suggest not to em-
phasise the term Bperforation^ in the radiological report,
since its does not require treatment [8, 18, 19].
Finally, reversible oedematous-type mural thickening
consistent with acute duodenitis (Fig. 3) may be ob-
served following therapeutic ERCP [20].
Role and limitations of ultrasound and magnetic resonance
imaging (MRI)
Compared to CT, sonographic investigation of patients
with suspected post-ERCP complications is strongly
limited by the usual abdominal distension due to ileus,
pneumoperitoneum or pneumoretroperitoneum and by its
inability to assess pancreatic necrosis and bleeding.
Practically, ultrasound may be useful for rapid assess-
ment of the gallbladder and biliary tree (with or without
stents) and for follow-up of known collections, and its
use is not recommended by current practice guidelines
[6, 12, 14, 21].
An increasingly attractive alternative modality, MRI
can image PEAP and abnormal collections without use
of ionising radiation, and it is particularly beneficial in
young patients. Unenhanced T1- and T2-weighted se-
quences with and without fat suppression may be
Fig. 1 During endoscopic retrograde cholangiopancreatography
(ERCP), a 65-year-old female with sphincter of Oddi dysfunction expe-
rienced duodenal perforation (DP), which was recognised
intraprocedurally and treated with endoluminal clipping. Twenty-four
hours later, unenhanced multidetector CTobtained after peroral ingestion
of enteral contrast medium (CM) and viewed at the bone window setting
showed a well-opacified gastroduodenal lumen without extraluminal CM
leak, consistent with sealed DP. Note the persistent extensive retroperito-
neal air (+) and metallic clips (arrowhead in B)
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complemented with MRCP sequences to assess the bil-
iary and pancreatic ducts and with additional dynamic
fat-suppressed T1-weighted gradient echo sequences
during intravenous gadolinium contrast when pancreatic
necrosis is suspected. Furthermore, diffusion-weighted
MRI may be more sensitive in detecting cases of mild
pancreatic inflammation. However, despite recent techni-
cal advancements MRI remains limited in acutely ill or
uncooperative patients, and the presence or pneumobilia
often renders MRCP sequences uninformative or confus-
ing [13, 22, 23].
Acute pancreatitis
Arguably the most common serious adverse event,
PEAP has been reported with variable incidence (2–
9 % overall, approximately 3.5 % in a meta-analysis
of several prospective studies, and up to 30 % of high
risk cases) according to patient selection. A transient
asymptomatic increase in serum pancreatic enzymes oc-
curs in the majority (70–75 %) of patients within 4 h
after ERCP and resolves within 4 days. According to
the widely used consensus definition adopted by the
ASGE guidelines, diagnosis of PEAP requires at least
two of the three following criteria: (1) consistent new-
onset or worsening abdominal pain (persistent, severe,
epigastric pain often radiating to the back); (2) new or
prolongation of hospitalisation for at least 2 days; (3)
abnormally elevated (at least three times above the up-
per normal limit) serum lipase or amylase 24 h after the
procedure [2, 6, 21].
The multifactorial pathogenesis of PEAP involves
mechanical factors (such as direct trauma from endosco-
py, difficult bile duct cannulation and multiple pancre-
atic duct injections) along with enzymatic, microbiolog-
ical and patient-related factors including history of aller-
gy [24–26]. The role of iodinated CM as one of the
cofactors in causing PEAP has been extensively studied.
In experimental models of acute pancreatitis, digestive
enzyme activation occurs rapidly within acinar cells fol-
lowing an initiating event: secretion blockage leads to
accumulation of zymogen granules within cells, their
fusion into large vacuoles, enzyme activation and finally
cellular injury [24]. Besides the reduced pancreatic
blood flow due to CM hyperviscosity, controversy exists
on the role of the chemical effect of CM osmolality.
Earlier studies reported reduced rates of pancreatic dam-
age and decreased with newer low- or iso-osmolar com-
pared to high-osmolar contrast medium, but other
Fig. 2 Normal findings observed
hours after operative ERCP in a
75-year-old male investigated
with unenhanced CT (c, d) to
verify correct placement of a
plastic biliary stent, including de-
pendent contrast medium
(arrows) and air (arrowheads) in
the intrahepatic bile ducts. In a
different patient, a 44-year-old
female patient suffering from
acute post-procedural pain,
contrast-enhanced CT (a, b)
2 days after ERCP excluded signs
of acute complications and
showed stratified iodinated con-
trast medium (*), bile and air (thin
arrow) in the gallbladder
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reports including a meta-analysis did not confirm a sig-
nificantly different risk and outcome of PEAP [25–28].
Probably unavoidable even in the hands of experienced
endoscopists, PEAP is associated with established risk condi-
tions including patient-specific (age below 55 years, female
gender, SOD, history of AP) and procedure-related factors
(difficult cannulation, standard or pre-cut sphincterotomy).
Whereas the risk of bleeding and perforation is similar to that
of younger patients, the elderly are less likely to experience
PEAP. Clinical guidelines increasingly suggest pharmacolog-
ic prophylaxis with nonsteroidal anti-inflammatory drugs,
glyceryl trinitrate or somatostatin; furthermore, in patients
with SOD, the use of temporary pancreatic duct stenting has
been proposed to limit the risk and severity of PEAP.
Fig. 3 Acute reversible duodenitis following ERCP. A 78-year-old male
with common bile duct (CBD) carcinoma causing concentric stenosis of
the proximal choledochus suffered from acute diffuse abdominal pain
without peritonitis 24 h after ERCP including cytological brushing and
positioning of a 10-French plastic biliary stent. Urgent contrast-enhanced
CT (a, b) showed a correctly placed biliary stent, appearance of moderate
ascites (*) and of marked circumferential thickening of the duodenum
from the Vaterian papilla to the Treitz angle, with enhancing mucosa
and hypoattenuating oedematous submucosa (Btarget sign^, thin arrows),
and minimal associated inflammatory changes in the periduodenal fat.
Imaging findings, laboratory data and the subsequent course excluded
iatrogenic pancreatitis, haemorrhage and DP. Three weeks later, the plas-
tic biliary stent was removed and replaced with a self-expanding metal
stent (SEMS). Follow-up CT (d) showed imaging resolution of both bil-
iary obstruction and acute duodenal inflammatory changes [partly
reprinted from Ref. 20]
Table 1 Classification of duodenal perforations according to Stapfer et al. (Ref. 8)
Type Description Comment
I Endoscope-related lateral or medial duodenal wall perforations Often large and distant from the ampulla, requires surgical
intervention in most cases
II Retroperitoneal peri-Vaterian perforations resulting from (pre-cut)
sphincterotomy
Of variable severity but most often discrete and amenable to
conservative management
III Distal common bile duct injuries secondary to guidewire insertion or
instrumentation for stone extraction
Amenable to conservative management
IV Isolated retroperitoneal air from excessive insufflation Does not require specific treatment
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Treatment is analogous to that of non-iatrogenic AP, and mor-
tality reaches 3 % of cases [2, 6, 21].
In patients with consistent above-mentioned clinical
and laboratory criteria following ERCP, early imaging
is generally unnecessary to diagnose PEAP, and during
the first week organ failure and systemic inflammatory
response syndrome (SIRS) may be present with few
local complications. Although not specifically developed
for iatrogenic occurrences, the revised Atlanta classifica-
t ion di f fe ren t ia tes morphologica l ly in te rs t i t i a l
oedematous (IEP) from necrotising acute pancreatitis
(NAP), the latter associated with a high probability of
infection, subsequent organ failure and increased mortal-
ity (12–30 % versus below 3 %). CT diagnosis of IEP
relies on diffuse or localised enlargement of the pancre-
atic parenchyma with preserved homogeneous enhance-
ment (to 80–150 HU) after intravenous CM, accompa-
n i e d by p e r i p a n c r e a t i c f a t s t r a n d i n g o r b y
hypoattenuating (0–30 HU) acute peripancreatic fluid
collections (APFCs). Containing a mixture of exudates,
necrosis and blood, APFCs are adjacent to the pancreas
and confined by normal fascial planes, and they display
homogeneous low (0–30 HU) attenuation without a dis-
cernible wall and enhancement [22, 23].
Nevertheless, in our experience CT is requested with-
in 24–72 h in most patients with clinical and laboratory
features indicating PEAP to exclude other complications
(particularly DP) with similar manifestations. Therefore,
a majority of patients with IEP are imaged with near-
normal or subtle CT findings, including a homoge-
neously enhancing pancreas, fat stranding and minimal
fluid around the head and neck of the pancreas (Figs. 4
and 5). Borrowing from experience with gallstone AP,
early contrast-enhanced CT obtained within 2–3 days
from the onset of symptoms may underestimate the se-
verity of PEAP including confident exclusion of necro-
sis so that repeated scanning may be required during
post-ERCP hospitalisation [13, 15, 16, 22, 23].
Fig. 4 Oedematous acute pancreatitis (AP) in a 77-year-old female 3 days
after endoscopic treatment of choledocholithiasis including
sphincterotomy. Unenhanced (a) and post-contrast (b) CT images showed
persistent moderately hyperattenuating contrast medium (*) in the gall-
bladder, oedema and fluid in the pancreatico-duodenal groove (arrows),
minimal ascites (+) consistent with clinical and laboratory features of
mild AP, and excluded abnormal collections and non-enhancing paren-
chyma indicating pancreatic necrosis. The patient had an uneventful
course with conservative treatment
Fig. 5 Oedematous AP with
markedly increased serum lipase
48 h after ERCP treatment of
choledocholithiasis in a 55-year-
old male with previous history of
biliary AP and laparoscopic cho-
lecystectomy. Unenhanced CT (a)
and T2-weighted MRI (b) images
show mild peripancreatic and ret-
roperitoneal fascial fluid (thin
arrows) without abnormal collec-
tions. Clinical symptoms and
laboratory changes regressed
within 72 h
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Conversely, NAP includes fatty tissue necrosis in ei-
ther the pancreatic parenchyma or peripancreatic tissue
and corresponds at imaging to pancreatic enlargement,
heterogeneous because of single or multiple areas of
diminished or absent enhancement consistent with ne-
crosis (Figs . 6 and 7) . In NAP, post -necrot ic
peripancreatic fluid collections (PNPFCs) are commonly
observed in the pancreas, peripancreatic tissue or both.
PNPFCs contain fluid, necrosis and/or loculation in
varying degrees. Differentiation from APFCs is very
difficult in the early phase and is generally based on
the presence or absence of glandular necrosis. PNPFCs
may become progressively more organised and encapsu-
lated later and are termed walled-off pancreatic necrosis
after 4 weeks of symptom onset (Fig. 7) [13, 15, 16,
22, 23].
Therefore, the radiologist’s role mostly relies in the
identification of the presence and extent of necrosis.
Severity of AP may be graded according to the modi-
fied CT severity index (M-CTSI), which takes into
account the presence of pancreatic and/or peripancreatic
inflammatory changes, APFCs, necrosis (<30 %, 30–
50 % and over 50 %) and extrapancreatic complications
such as pleural effusion, ascites, vascular or gastrointes-
tinal involvement. The only large specific series graded
PEAP severity according to M-CTSI scores as mild (≤2
points), moderate (4–6) and severe (≥8) in 53.6, 42.8
and 3.6 % of cases respectively [13, 15, 16, 22, 23].
Furthermore, peripancreatic and glandular changes
consistent with PEAP are well demonstrated by MRI
(Figs. 5 and 6). Typical MRI findings of AP include var-
iable degrees of glandular enlargement with mildly in-
creased T2-weighted signal intensity corresponding to oe-
dema, normal signal on fat-saturated T1-weighted acqui-
sitions, peripancreatic inflammatory fat stranding, fluid or
collections. Similarly to CT, pancreatic enhancement may
appear homogeneous (in IEP), diminished or heteroge-
neous (in NAP) after intravenous gadolinium CM. In the
setting of gallstones, it has been proposed that a limited
noncontrast MRI protocol has high correlation with
Fig. 7 Necrotising AP plus retroperitoneal air in a 79-year-old male
occurring 48 h after ERCP treatment of choledocholithiasis, including
sphincterotomy. Contrast-enhanced CT (a, b) showed an enlarged, mark-
edly inhomogeneous, poorly enhancing pancreas with fascial (thin arrow
in a), peripancreatic and infrahepatic (+ in b) fluid, gas bubbles along the
superior mesenteric vessels and in the periduodenal region. Pleural effu-
sion was present bilaterally. Urgent laparotomic surgery confirmed severe
necrotic-haemorrhagic pancreatitis. During his prolonged stay in the in-
tensive care unit, follow-up unenhanced CT (c) showed the appearance of
a vast walled-off postnecrotic collection (*)
Fig. 6 Necrotising AP in a 73-year-old male after ERCP including en-
doscopic treatment of mild bleeding after papillotomy. Urgent MRI (T2-
weighted image in a) requested because of increased C-reactive protein
(CRP), leukocyte count and serum lipase showed a markedly enlarged
pancreatic gland (*) with peripancreatic oedema. Contrast-enhanced CT
(b, c) confirmed severe AP with inhomogeneous enhancement of the
enlarged pancreas due to diffuse peripancreatic necrosis (+). The patient
finally recovered after 2 weeks of in-hospital conservative treatment
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contrast-enhanced CT in the assessment of mild AP. Fur-
thermore, the use of diffusion-weighted MRI including
measurement of apparent diffusion coefficients (ADCs)
may allow differentiation among normal, inflamed and
necrotic pancreas before or without CM administration
[22, 23, 29, 30].
Haemorrhage
Primarily a complication related to sphincterotomy
rather than to diagnostic ERCP, bleeding may be im-
mediate or delayed up to 2 weeks (in up to 50 % of
cases) and is clinically suggested by haematemesis,
melaena or haemoglobin drop. Whereas variable de-
grees of bleeding occur in approximately 1–2 % of
treated patients, haemorrhage is graded as mild (ac-
cording to blood loss and transfusion need) in approx-
imately 70 % of cases, with occasional mortality
(0.3 %). Specific risk factors include coagulopathy,
therapeutic anticoagulation, haemodialysis, acute
cholangitis or papillary stenosis, pre-cut or extended
sphincterotomy [2, 6].
Although clinically significant haemorrhage requiring
angiographic, endoscopic or surgical intervention is rare
(less than 1/1,000 sphincterotomies), CT imaging may
help in the diagnosis by showing hyperattenuating fluid
consistent with blood in the choledochus (Fig. 8) or
duodenal lumen. Residual diluted CM in the duodenal
or jejunal lumen may sometimes be confused with fresh
haemorrhage. Alternatively, intramural bleeding may ap-
pear as high-attenuation duodenal wall thickening.
Arterial-phase acquisition completed with maximum-
intensity projection (MIP) reconstructions at vascular
window settings may effectively show active contrast
extravasation in the duodenum, indicating ongoing
bleeding (Fig. 9). Furthermore, following operative
ERCP bleeding may occasionally form intrahepatic or
subcapsular hepatic haematomas with associated
haemoperitoneum (Fig. 10) [13, 31, 32].
Fig. 8 Haemobilia following ERCP in a 57-year-old female with benign
papillary stenosis and previous cholecystectomy, manifesting with ab-
dominal pain and mild haemoglobin drop. Unenhanced (a, b) and post-
contrast (c) CT images showed moderate dilatation and hyperattenuating
(45 HU) content of the CBD (arrowheads) corresponding to endoluminal
haemorrhage but initially misinterpreted as retained CM injected during
the procedure, without signs of active bleeding. This complication was
self-limiting and resolved on conservative treatment
Fig. 9 Acute intraluminal bleeding in the duodenum manifesting with
acute abdominal pain and impending haemodynamic shock, hours after
an unsuccessful endoscopic attempt to relieve the intrahepatic biliary
obstruction in 77-year-old female with recently diagnosed infiltrating
gallbladder carcinoma. Operative ERCP was interrupted after
sphincterotomy because of duodenal haemorrhage, which was treated
with epinephrine injection and endoluminal clipping. Comparison of
unenhanced (a) and arterial-phase (b, c) CT images detected active con-
trast extravasation in the duodenal lumen (arrowheads) abutting the me-
tallic clips (thin arrows), consistent with persistently ongoing arterial
haemorrhage. Endovascular therapeutic embolisation of the gastroduode-
nal artery was necessary to control bleeding
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The CT detection of active bleeding represents an
indication for endoscopic, interventional or surgical
treatment. The generally accepted first-line treatment to
control bleeding is repeated endoscopy with several
haemostatic methods such as flushing with epinephrine
solution, balloon tamponade, haemostatic (fibrin glue)
injection, hemoclip placement, electrocoagulation or
temporary stent placement. When endoscopic procedures
fail, bleeding control requires interventional radiological
embolisation or surgery [33–36].
Duodenal perforation
Representing the rarest yet most feared occurrence, DP com-
plicates 0.1–1 % of ERCP procedures and is associated with a
non-negligible mortality rate (9–18 %). DP is mostly associ-
ated with standard (using an electrical papillotome catheter) or
pre-cut (with a needle knife) sphincterotomy extending be-
yond the intramural CBD portion and with guidewire manip-
ulation. Other risk factors for ERCP-related perforation in-
clude dilated CBD, stricture dilatation, SOD, presence of
peripapillar diverticula and previous Billroth II surgery [2,
6–8, 14, 19, 37, 38].
In a variable proportion (26–48 %) of patients DP is
suspected or verified during ERCP by means of CM
injection through the endoscope showing extraluminal
CM leakage (Fig. 11). Alternatively, clinical presenta-
tion occurs hours or days later, may be closely similar
to those associated with PEAP and is not unusually
mild compared to the imaging findings [2, 6–8, 14,
37, 38].
The classification system proposed by Stapfer et al.
(Table 1) categorises DP into four classes in descending
order of severity, on the basis of the mechanism and
anatomical location, in order to predict the need for
surgery [8].
Although controversy exists about the optimal ap-
proach, the management of ERCP-related DP should
be individualised according to its type, clinical picture
and imaging findings. Whereas type I (endoscope-
related) duodenal wall perforations invariably require
early surgery, the majority (approximately 70 %) of pa-
tients with peri-Vaterian (type II) DP tend to seal spon-
taneously and thus are amenable to endoclipping
(Fig. 1) or conservative management (nasogastric drain-
age, nil-by-mouth and parenteral nutrition, intravenous
hydration and antibiotics). Currently, the therapeutic ap-
proach to management of stable patients is increasingly
Fig. 10 A 39-year-old male with
previous Bismuth type II iatro-
genic bile duct injury during lap-
aroscopic cholecystectomy
10 months earlier, shown in a
coronal thick-slab MR cholangi-
ography (MRCP) image (thin ar-
rows in a), which required imme-
diate reintervention to remove the
surgical clips plus temporary
plastic biliary stenting. Note
haematoma in the gallbladder
fossa (§). Twenty-four hours after
endoscopic positioning of the
covered metallic biliary stent (b),
he suffered from sudden abdomi-
nal pain, vomiting and hypoten-
sion, and unenhanced (c) CT im-
ages detected a large
hyperattenuating subcapsular liv-
er haematoma (*) and
haemoperitoneum (+) attributed
to guidewire manoeuvres, which
progressed at repeated contrast-
enhancement CT on the next day
(d), thus dictating immediate sur-
gical evacuation
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nonsurgical and proves successful in approximately two-
thirds of cases: unfortunately, delayed recognition of
type I perforations and failure of conservative treatment
are associated with a high death rate (50 %) from sep-
sis. As from the WSES guidelines, accepted indications
for surgical treatment include clinical features such as
sepsis and peritonitis, imaging features (free intraperito-
neal air, periduodenal or retroperitoneal fluid collections,
contrast extravasation at ERCP, CT or upper gastrointes-
tinal study with water-soluble CM, retained stones or
basket/wire endoscopic instruments) and failure of con-
servative management. Surgery may include perforation
closure or duodenal exclusion, retroperitoneal drainage,
CBD exploration and T-tube insertion [2, 6, 8, 12, 14,
38–42].
The CT imaging hallmark of DP is represented by
extraluminal air, which may sometimes be located in the
duodenal wall, but most commonly dissects through the ret-
roperitoneal compartments. Due to the anatomic location of
the CBD, the typical appearance of a type II DP includes air
collecting posteriorly to the duodenum and pancreatic head, in
the anterior pararenal and right perirenal space, surrounding
the inferior vena cava, portal vein and splanchnic vessels, and
sometimes crossing the midline (Figs. 11, 12, 13 and 14).
Occasionally, air may track cranially in the posterior medias-
tinum [2, 8, 9, 13, 38].
However, the presence and amount of retroperitoneal
air at imaging do not linearly correlate with the severity
of the injury or with the need for invasive treatment
since it rather reflects the degree of continuous endo-
scopic air insufflation and manipulation after an unde-
tected injury occurred. Therefore, successful nonopera-
tive management of type II DP with extensive retroper-
itoneal air is possible, provided that the patient does not
Fig. 11 An elderly 80-year-old male with multiple comorbidities
underwent endoscopic treatment of choledocholithiasis, including pre-
cut sphincterotomy of the Vaterian papilla and stone retrieval using a
basket device. During ERCP, fluoroscopy (a) showed opacification of
dilated intrahepatic and common bile ducts and of a sizeable extraluminal
CM collection (thin arrows) from lateral duodenal wall perforation (type I
according to the Stapfer classification system). A few hours later CT (b–
d) showed diffuse gaseous bowel distension from insufflation during
endoscopy, presence of posterior pneumomediastinum, perihepatic and
right parietocolic pneumoperitoneum (*), and extensive retroperitoneal
emphysema in the right perirenal, posterior and anterior pararenal spaces
(+). Note persistently opacified intrahepatic and common bile ducts with
residual lithiasis fragments (arrowheads), persistently extravasated CM
(arrow in d). Imaging findings and worsening clinical conditions with
peritonitis dictated urgent laparotomy, which confirmed intra-abdominal
free air, and included opening and toilette of common bile duct and
positioning of a Kehr T-tube. The patient finally recovered after a
prolonged hospital stay
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Fig. 12 Severe retroperitoneal
(type II) DP in an 80-year-old fe-
male following ERCP with
sphincterotomy, incomplete re-
moval of choledocholithiasis and
positioning of a plastic CBD
prosthesis (arrowhead). Post-
procedural unenhanced CT
viewed at both soft-tissue (a, b)
and bone (c, d) window settings
showed extensive retroperitoneal
air (+) predominantly located in
the right peri- and pararenal
spaces, around the descending
duodenum and tracking along the
inferior vena cava and portal vein
(thin arrows). Surgical explora-
tion dictated by sepsis failed to
detect a perforation site, and the
patient recovered fully
Fig. 13 Failed conservative
treatment of DP in an 83-year-old
male with chronic duodenal stric-
ture who underwent ERCP to
prevent further episodes of infec-
tious cholangitis. The next day,
contrast-enhanced CT (a) showed
moderate right-sided retroperito-
neal gas (*). Follow-up CT (b, c)
4 days later showed formation of
multiple confluent periduodenal
and right parietocolic fluid-like
infected collections (+), with ex-
tensive occupation of the ipsilat-
eral posterior pararenal space,
which required percutaneous
drainage (d) to relieve sepsis
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develop peritonitis, fever or impending shock. However,
negative physical findings do not reliably exclude sur-
gery since severe DP may be masked clinically by the
retroperitoneal site especially in elderly or chronically ill
patients. Extraluminal CM leak (Fig. 11), pneumoperito-
neum (Fig. 14) and fluid collections represent the key
imaging findings, which usually shift the therapeutic
approach towards surgery. During conservative treat-
ment, repeat CT may be warranted after a 48–72-h in-
terval to confirm sealed leaks and absent fluid collec-
tions as well as to monitor the patient until recovery [2,
6, 12, 13, 15].
Post-procedural infections
Although the current guidelines recommend antibiotic
prophylaxis in known or suspected biliary obstruction,
bacteraemia is a common event (15–27 %) after diag-
nostic or therapeutic ERCP. The reported incidence of
Fig. 14 Stapfer type I DP with moderate retroperitoneal air (+) plus
pneumoperitoneum extending to the scrotum (*) shown by emergency
unenhanced CT in a 62-year-old male undergoing ERCP treatment of
choledocholithiasis. Laparotomic surgery included duodenotomy and
suture of a posterior duodenal wall discontinuity, toilette and drainage
of the peritoneal cavity. The subsequent course was uneventful and re-
peated CTwith oral CM at discharge (not shown) excluded extraluminal
contrast leak
Fig. 15 Acute cholecystitis in a
66-year-old female manifesting
with fever and transverse upper
abdominal pain 3 days after
ERCP with sphincterotomy and
biopsy of ampullary adenoma in-
cluding antibiotic prophylaxis.
Multiplanar contrast-enhanced
CT images show a thickened
gallbladder wall (arrows) with
focal perforation (arrowhead in c)
and localised collection (*),
which required emergency
laparotomic cholecystectomy.
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clinically significant iatrogenic infections is limited (1–
3 %), but sepsis represents a common cause of death.
Specific risk factors for infection include stenting across
tumours, obstructed ducts and jaundice, combined
percutaneous-endoscopic procedures, primary sclerosing
cholangitis, incomplete or failed biliary drainage [2, 6].
The spectrum of post-ERCP infectious complications
encompasses cholecystitis, septic cholangitis, liver ab-
scess and systemic sepsis. Occurring in approximately
0.2–0.5 % of patients, cholecystitis has been correlated
to cholelithiasis and intraprocedural filling of the gall-
bladder with CM, and it is heralded by the appearance
Fig. 16 Cholangitis and sepsis in
an 81-year-old female following
endoscopic stone removal using a
Fogarty catheter. Multiplanar
contrast-enhanced CT images
showed minimal pneumoperito-
neum (arrowheads) and peritone-
al effusion, thickened enhancing
walls of CBD and main
intrahepatic ducts (thin arrows).
Additionally, left-sided pneumo-
nia (* in c) and a limited renal
infarct (arrow in d) were seen.
Worsening clinical conditions
dictated surgery, which revealed
biliary peritonitis from contained
cystic duct injury. The patient re-
covered after a long intensive care
unit stay
Fig. 17 Perihepatic abscess diagnosed 10 days after endoscopic stent
positioning through a cytologically benign distal CBD stricture in a 78-
year-old female. Contrast-enhanced CT (a) requested because of fever
and right hypochondrium pain revealed a fluid-like collection (*) with
an enhancing peripheral rim and minimal extraluminal air (+) predomi-
nantly in the right-sided retroperitoneum. Urgent surgery included chole-
cystectomy and abscess drainage. Postoperatively, unenhanced T2-
weighted MRI (b) depicted resolution of the abscess (arrowheads)
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of luminal overdistension and circumferential mural
thickening (Fig. 15). Septic cholangitis is suggested by
thickened enhancing CBD and intrahepatic duct walls
(Fig. 16). Accessory signs of sepsis such as atelectasis/
pneumonia, splenic or renal infarcts may be observed
(Fig. 16). Alternatively, sepsis may result from superin-
fection of PNPFCs or abnormal collections from DP
(Fig. 13). Abscess collections usually display enhancing
mural thickening, similar attenuation to that of non-
infected fluid collections and sometimes internal gas
bubbles (Figs. 17 and 18) [6, 13, 15].
Stent-related complications
Relatively rare, early complications after biliary stenting in-
clude haemorrhage (Fig. 10), PEAP, stent misplacement, per-
foration (Fig. 19) and injury to the CBD or main pancreatic
duct [13, 17].
Chronic stent-related complications are more common and
include stent obstruction (25–35 % of patients), migration,
fracture or collapse, infections such cholangitis, liver abscess
(Fig. 18) or sepsis. Biliary stent dislodgement (Fig. 18) occurs
after a variable time interval in up to 6 % of patients
Fig. 19 In a 60-year-old male
with severe chronic calcific pan-
creatitis, after ERCP positioning
of the metallic pancreatic stent
(arrowhead in a) contrast-
enhanced CT showed minimal
intraperitoneal air (*), which was
treated conservatively with suc-
cess. Note pneumobilia (arrows)
and retained CM in the
gallbladder
Fig. 18 One month after evacuation of the haemoperitoneum and
subcapsular hepatic haematoma, the same patient in Fig. 10 suffered
form right-sided thoraco-abdominal pain and fever. Arterial- (a) and
venous-phase (b) CT showed a huge, fluid-attenuating (15 HU)
subphrenic collection (*) with inflammatory enhancement of the sur-
rounding, compressed liver parenchyma (+) and thin peripheral enhance-
ment, consistent with an abscess. Ipsilateral pleural effusion and basal
lung atelectasis were associated. Percutaneous drainage yielded 3 l of
stinking pus. Note the correctly positioned metallic CBD stent
(arrowheads), and clinical, laboratory and imaging (* in c) resolution
was obtained. During endoscopic replacement, the biliary stent was not
found anymore (d), displaced and probably lost with stools. Endoscopic
cholangiogram (e) confirmed persistent iatrogenic biliary stricture
(arrow). Follow-up MRI (T2-weighted image in f) showed resolved
subphrenic abscess with low signal intensity consistent with fibrosis (*)
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and is more frequent with plastic stents compared to
SEMS. Displacement may be proximal, particularly in
patients with malignant obstruction, or alternatively dis-
tal to the intestine, the latter not unusually asymptomat-
ic [4, 5, 17, 43, 44].
Conclusion
Diagnosis and management of post-ERCP complications
should combine clinical and laboratory data with imaging ap-
pearances. Urgent CT imaging is crucial to promptly identify
and categorise the most common and unusual complications
after ERCP, particularly to triage those occurrences that re-
quire prolonged in-hospital treatment or surgical reoperation.
Knowledge of ERCP procedural details, the appropriate CT
acquisition technique and familiarity with normal appearances
are needed to diagnose and grade oedematous or necrotic
PEAP, bleeding, DP and infections, which may have similar,
nonspecific clinical and laboratory manifestations [2, 6, 12].
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